MiniPDX Mouse Trial for Indication Screening

  • MiniPDX has been widely accepted by more and more physicians in China to determine the best therapeutic strategy for indicated patient in a precision medicine manner (Learn More). In this way, LIDE has easy access to fresh tumor samples with various indication, which facilitate sensitivity validation for candidate new drug(s) in selected indication(s) via MiniPDX Mouse Trial that beyond clinical individualized therapy. 

MiniPDX Mouse Trial for Indication Screening